FDA Inspection
Waterstone Pharmaceuticals Co., Ltd.Waterstone Pharmaceuticals Co., Ltd. – FDA Inspection, Jan 20, 2017
Record Details
This FDA Inspection record concerns Waterstone Pharmaceuticals Co., Ltd., with an inspection on January 20, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 8e010674-977b-477f-8978-03971319a656
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 999796
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Waterstone Pharmaceuticals Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Waterstone Pharmaceuticals Co., Ltd.
- FDA Inspection 1155058 - 2021-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.